Literature DB >> 33835503

Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer.

Giulia Fiscon1,2, Silvia Pegoraro3, Federica Conte1, Guidalberto Manfioletti3, Paola Paci1,4.   

Abstract

Among breast cancer subtypes, triple-negative breast cancer (TNBC) is the most aggressive with the worst prognosis and the highest rates of metastatic disease. To identify TNBC gene signatures, we applied the network-based methodology implemented by the SWIM software to gene expression data of TNBC patients in The Cancer Genome Atlas (TCGA) database. SWIM enables to predict key (switch) genes within the co-expression network, whose perturbations in expression pattern and abundance may contribute to the (patho)biological phenotype. Here, SWIM analysis revealed an interesting interplay between the genes encoding the transcription factors HMGA1, FOXM1, and MYBL2, suggesting a potential cooperation among these three switch genes in TNBC development. The correlative nature of this interplay in TNBC was assessed by in vitro experiments, demonstrating how they may actually modulate the expression of each other.
© 2021 Federation of European Biochemical Societies.

Entities:  

Keywords:  correlation networks; network medicine; triple-negative breast cancer

Year:  2021        PMID: 33835503     DOI: 10.1002/1873-3468.14085

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.

Authors:  Barbara Belletti; Guidalberto Manfioletti; Michela Sgubin; Silvia Pegoraro; Ilenia Pellarin; Gloria Ros; Riccardo Sgarra; Silvano Piazza; Gustavo Baldassarre
Journal:  Cell Death Dis       Date:  2022-05-03       Impact factor: 9.685

2.  In silico recognition of a prognostic signature in basal-like breast cancer patients.

Authors:  Federica Conte; Pasquale Sibilio; Anna Maria Grimaldi; Marco Salvatore; Paola Paci; Mariarosaria Incoronato
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.240

3.  A Comparison of Network-Based Methods for Drug Repurposing along with an Application to Human Complex Diseases.

Authors:  Giulia Fiscon; Federica Conte; Lorenzo Farina; Paola Paci
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 4.  Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?

Authors:  Marta Marqués; Maria Alba Sorolla; Izaskun Urdanibia; Eva Parisi; Iván Hidalgo; Serafín Morales; Antonieta Salud; Anabel Sorolla
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

5.  Identification of fibronectin 1 (FN1) and complement component 3 (C3) as immune infiltration-related biomarkers for diabetic nephropathy using integrated bioinformatic analysis.

Authors:  Yuejun Wang; Mingming Zhao; Yu Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.